Looking At Merck & Co., Inc. (NYSE:MRK) From All Angles

Attractive stocks have exceptional fundamentals. In the case of Merck & Co., Inc. (NYSE:MRK), there's is a well-regarded dividend payer with a strong history of delivering benchmark-beating performance. In the following section, I expand a bit more on these key aspects. For those interested in digging a bit deeper into my commentary, take a look at the report on Merck here.

Advertisement

Solid track record established dividend payer

MRK delivered a triple-digit bottom-line expansion over the past couple of years, with its most recent earnings level surpassing its average level over the last five years. This illustrates a strong track record, leading to a satisfying return on equity of 33%, which is an optimistic signal for the future.

NYSE:MRK Income Statement, August 16th 2019
NYSE:MRK Income Statement, August 16th 2019

For those seeking income streams from their portfolio, MRK is a robust dividend payer as well. Over the past decade, the company has consistently increased its dividend payout, reaching a yield of 2.6%.

NYSE:MRK Historical Dividend Yield, August 16th 2019
NYSE:MRK Historical Dividend Yield, August 16th 2019

Next Steps:

For Merck, there are three essential factors you should further examine:

  1. Future Outlook: What are well-informed industry analysts predicting for MRK’s future growth? Take a look at our free research report of analyst consensus for MRK’s outlook.
  2. Financial Health: Are MRK’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  3. Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of MRK? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About NYSE:MRK

Merck

Operates as a healthcare company worldwide.

Undervalued established dividend payer.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0776.3% undervalued
142 users have followed this narrative
1 users have commented on this narrative
24 users have liked this narrative
CL
Clive_Thompson
RMS logo
Clive_Thompson on Hermès International Société en commandite par actions ·

Hermès - Expensive bags, and expensive stock. And the story of €14 billion of bearer shares gone missing.

Fair Value:€1.51k24.9% overvalued
2 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
SU
LNG logo
superbullll on Cheniere Energy ·

Cheniere Energy (LNG) — The Toll Road That Geopolitics Just Made More Valuable

Fair Value:US$320.9421.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
SA
EBGNG logo
Salman2415 on GNG Electronics ·

Strong execution in a growing category, but long‑term value hinges on cash‑flow discipline

Fair Value:₹135.87177.0% overvalued
3 users have followed this narrative
1 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

AG
Agricola
DEX logo
Agricola on Almadex Minerals ·

A case for Almadex: conservative CAD 4.50–7.00 (x8–x12) to bull CAD 25–40+ (x42–x68+)

Fair Value:CA$1094.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
NBIS logo
Vestra on Nebius Group ·

Nebius Group NV (NBIS): The AI Infrastructure Pivot and the Meta Super-Contract

Fair Value:US$132.62.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
INTC logo
Vestra on Intel ·

Intel Corp (INTC): The 18A Node Pivot and the "Foundry First" Transformation

Fair Value:US$3338.7% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.377.8% undervalued
53 users have followed this narrative
3 users have commented on this narrative
29 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9823.3% undervalued
44 users have followed this narrative
0 users have commented on this narrative
33 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59632.9% undervalued
1312 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative